Prof. L. Zhuravlyova, O. Romanenko. Kharkiv National Medical University.

Hereditary disorders of connective tissue are diseases caused by diferent gene mutation and involve into pathologic process many organ systems, especially, cardiovascular, skeletomotor systems, eyes and skin. Marfan syndrome, Ehlers-Danlos syndrome, Loeys-Dietz syndrome are hereditary disorders which frequently damage cardiovascular system. Tese syndromes have common feature — formation of aneurysms of aorta or other vessels and risk of their dissection. Te article presents modern view on the etiology and pathogenesis of mentioned syndromes, current diagnostic criteria, novel achievements in therapeutic management and guidelines for surgical interventions in this group of patients.

Key Words: hereditary disorders, Marfan syndrome, vascular aneurysms.

Zhuravleva LV, Romanenko AR. [Involvement of cardiovascular system in hereditary disorders of connective tissue]. Shidnoevr. z. vnutr. simejnoi med. 2016;1:104-110. Russian.

http://dx.doi.org/10.15407/internalmed2016.01.104

Download.PDF

1. Achelrod D, Blankart CR, Linder R. [The economic impact of Marfan syndrome: a non-experimental, retrospective, population-based matched cohort study]. Orphanet Journal of Rare Diseases. 2014; (9): 90. English http://dx.doi.org/10.1186/1750-1172-9-90

2. Ades L. [CSANZ Guidelines for the diagnosis and management of Marfan Syndrome]. Heart, lung & circulation. 2011; 1 (16): 28−30. English

3. Ashok K, Sarita A. [Marfan syndrome: An eye-sight of syndrome]. Meta Gene. 2014; (2): 96−105. English

4. Baumgartner H, Bonhoeffer P, Groot DN. [ESC Guidelines for the management of grown-up congenital heart disease (new version 2010)]. European Heart Journal. 2010; 23 (31): 2915—2957. English

5. Beridze N, Frishman WH. [Vascular Ehlers-Danlos syndrome: pathophysiology, diagnosis, and prevention and treatment of its complications]. Cardiology in Review. 2012; (20): 4−7. English

6. Bernhardt AM, Treede H, Rybczynski M. [Comparison of aortic root replacement in patients with Marfan syndrome]. European Journal of Cardio-Thoracic Surgery: Official Journal of the European Association for Cardio-thoracic Surgery. 2011; 5 (40): 1052—1057. English

7. Bolar N, Van Laer L, Loeys BL. [Marfan syndrome: from gene to therapy]. Current opinion in pediatrics. 2012; (24): 498−504. English http://dx.doi.org/10.1097/MOP.0b013e3283557d4c

8. Byers PH, Murray ML. [Heritable collagen disorders: the paradigm of the Ehlers-Danlos syndrome]. The Journal of Investigative Dermatology.2012; (132): 6—11. English http://dx.doi.org/10.1038/skinbio.2012.3

9. Cattalini M, Khubchandani R, Cimaz R. [When flexibility is not necessarily a virtue: a review of hypermobility syndromes and chronic or recurrent musculoskeletal pain in children]. Pediatric Rheumatology Online Journal. 2015; (13): 40 English http://dx.doi.org/10.1186/s12969-015-0039-3

11. Goldfinger JZ, Halperin JL, Marin ML. [Thoracic aortic aneurysm and dissection]. Journal of the American College of Cardiology. 2014; 16 (64): 1725−1739. English http://dx.doi.org/10.1016/j.jacc.2014.08.025

12. Gu XH, Li Z, Han J. [Marfan syndrome: echocardiographic valvular characteristics compared to histological finding]. Journal of the American College of Cardiology. 2011; (57): 1410. English http://dx.doi.org/10.1016/S0735-1097(11)61410-1

13. Habashi JP, Doyle JJ, Holm TM. [Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism]. Science. 2011; 6027 (332): 361—365. English http://dx.doi.org/10.1126/science.1192152

14. Hiratzka LF, Bakris GL, Beckman JA. [2010 ACCF/AHA/AATS/ACR/ASA/SCA/ SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease: a report of the American college of cardiology foundation/ American heart association task force on practice guidelines, American association for thoracic surgery, American college of radiology, American stroke association, society of cardiovascular anesthesiologists, society for cardiovascular angiography and interventions, society of interventional radiology, society of thoracic surgeons, and society for vascular medicine].Circulation. 2010; 13 (121): 266—369. English

15. Kahveci G, Erkol A, Yilmaz F. [Dilated cardiomyopathy in a patient with Marfan syndrome accompanied by chronic type A aortic dissection and right atrial thrombus]. Internal Medicine. 2010; 23 (49): 2583—86. English http://dx.doi.org/10.2169/internalmedicine.49.3880

16. Laer LV, Proost D, Loeys BL. [Connective tissue disorders with vascular involvement: from gene to therapy] European Journal of Pediatrics. 2013; (172): 997—1005. English http://dx.doi.org/10.1007/s00431-012-1773-x

17. Liang C, Fan W, Wu S. [Identification of a novel FBN1 mutation in a Chinese family with isolated ectopia lentis]. Molecular Vision. 2011; (17): 3481−3485. English

18. Loeys BL, Schwarze U, Holm T. [Aneurysm syndromes caused by mutations in the TGF-beta receptor]. New England Journal of Medicine. 2006; (355): 788—798. English http://dx.doi.org/10.1056/NEJMoa055695

19. Loeys BL, Dietz HC, Braverman AC. [The revised Ghent nosology for the Marfan syndrome]. Journal of Medical Genetics. 2010; (47): 476−485. English http://dx.doi.org/10.1136/jmg.2009.072785

20. Micheal S, Khan MI, Akhtar F. [Identification of a novel FBN1 gene mutation in a large Pakistani family with Marfan syndrome]. Molecular Vision. 2012; (18): 1918−1926. English

21. Mimoun L, Detaint D, Hamroun D. [Dissection in Marfan syndrome: the importance of the descending aorta]. European Heart Journal. 2011; 4 (32): 443—449. English http://dx.doi.org/10.1093/eurheartj/ehq434

22. Ong KT, Perdu J, De Backer J. [Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial]. Lancet. 2010; (376): 1476— 1484. English http://dx.doi.org/10.1016/S0140-6736(10)60960-9

23. Pepin MG, Byers PH, authors. [Ehlers-Danlos syndrome, vascular type In GeneReviews at GeneTests: Medical Genetics Information Resource (database online). Seattle: University of Washington. 1993-2011. Available from http://www.ncbi.nlm.nih.gov/books/NBK1494.

24. Plancke A, Holder EM, Rigau V. [Homozygosity for a null allele of COL3A1 results in recessive Ehlers—Danlos syndrome]. European Journal of Human Genetics. 2009; 11 (17): 1411− 1416. English http://dx.doi.org/10.1038/ejhg.2009.76

25. Pomianowski P, Elefteriades JA. [The genetics and genomics of thoracic aortic disease]. Annals of Cardiothoracic Surgery. 2013; 3 (2): 271—279. English

26. Ramlingam G, Natarajasundaram UM. [Ghent Criteria an Aid to Diagnose Latent Systemic Diseases in Marfan Syndrome]. Journal of Clinical and Diagnostic Research : JCDR. 2015; 5 (9): 1− 2. English

27. Refaat M, Hotait M, Winston B. [Homozygous factor V Leiden mutation in type IV Ehlers-Danlos patient]. World Journal of Clinical Cases. 2014; 3 (2): 75− 77. English

28. Shields LB, Rolf CM, Davis GJ. [Sudden and unexpected death in three cases of Ehlers-Danlos syndrome type IV]. Journal of Forensic Sciences. 2010; 6 (55): 1641—1645. English http://dx.doi.org/10.1111/j.1556-4029.2010.01521.x

29. Suh YJ, Kwon HW, Kim GB. [A case of near total aortic replacement in an adolescent with Loeys-Dietz syndrome]. Korean Circulation Journal. 2012; (42): 288−291. English http://dx.doi.org/10.4070/kcj.2012.42.4.288

30. Laar VD, Oldenburg RA, Pals G. [Mutations in SMAD3 cause a syndrome form of aortic aneurysms and dissections with early-onset osteoarthritis]. Nature genetics. 2011; (43): 121—126. English http://dx.doi.org/10.1038/ng.744

31. Wiesmann T, Castori M, Malfait F. [Recommendations for anesthesia and perioperative management in patients with Ehlers-Danlos syndrome(s) Orphanet]. Journal of Rare Diseases. 2014; 109 (9): 145—178. English